Chemoinformaics analysis of Chrysanthenone epoxide
| Molecular Weight | 166.22 | nRot | 0 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 11 |
| Exact Molecular Weight | 166.099 | nRing | 4 |
| Solubility: LogS | -1.547 | nHRing | 1 |
| Solubility: LogP | 1.876 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 27.6391 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.509 |
| Synth | 5.247 |
| Natural Product Likeliness | 2.722 |
| NR-PPAR-gamma | 0.081 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.586 |
| MDCK | 0.0000423 |
| BBB | 0.983 |
| PPB | 0.345794 |
| VDSS | 1.856 |
| FU | 0.700449 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.331 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.85 |
| CYP2c9-inh | 0.079 |
| CYP2c9-sub | 0.203 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.588 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.239 |
| CL | 16.001 |
| T12 | 0.252 |
| hERG | 0.015 |
| Ames | 0.031 |
| ROA | 0.625 |
| SkinSen | 0.355 |
| Carcinogencity | 0.047 |
| EI | 0.772 |
| Respiratory | 0.977 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.914356 |